13F-HR filed by venBio Partners LLC
venBio Partners LLC filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 6 holding rows worth $210,789,000.
- Accession
- 0001776382-19-000002
- Filer
- CIK 1776382
- Filed
- 2019-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2019
A holdings report, 6 entries on the cover page, a total value of $210,789,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $210,789,000 with VALUE read as thousands by filing date, 13F file number 028-19529. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 3,954,858 | $89,973,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 1,340,265 | $50,394,000 | thousands by filing date | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 4,265,141 | $35,785,000 | thousands by filing date | |
| Apellis Pharmaceuticals, Inc | 037530106 | COM | 1,000,000 | $24,090,000 | thousands by filing date | |
| MENLO THERAPEUTICS INC | 586858102 | COM | 1,461,552 | $6,548,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 875,000 | $3,999,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001776382-19-000002 | this filing | 2019-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-20-010846 | base | 2020-05-20 | acceptance time not in the bulk data set |